title: In vivo and in vitro effects of QHF combined with chemotherapy on hepatocellular carcinoma.
abstract: OBJECTIVE
  To investigate the synergistic anti-tumor effect of QHF (a Chinese medicine formula with anti-tumor active ingredients, including 800 mg/kg Cinobufotalin, 14 mg/kg Ginsenoside Rg3, 5.5 mg/kg Notoginseng and 100 mg/kg Lentinan) when combined with the chemotherapy drug cisplatin (DDP).
  
  
  METHODS
  Hepatocellular carcinoma H22 cells were implanted into mice and after the transplants were successfully established the animals were divided into four groups, namely a normal saline(NS) control group, QHF group, DDP group and QHF+DDP group. The tumor growth was monitored and the survival time determined. In vitro studies employing H22 cells used the first three groups, and determined the effects of QHF and DDP on tumor cell cycle distribution, apoptosis and morphologic changes in vitro.
  
  
  RESULTS
  QHF significantly inhibited the growth of tumors and prolonged the survival time of mice with hepatocellular carcinomas. QHF combined with DDP could attenuate DDP-induced leucopenia, spleen and thymus atrophy and other indicators of toxicity. The inhibition rate of tumor growth reached 82.54% with QHF+DDP, and QHF prolonged the life span of DDP-treated mice by 66.83%. In the in vitro experiments tumor cells showed morphological changes characteristic of apoptosis by both light and transmission electron microscopy in the QHF group, and the apoptosis rate was 33.85%. Moreover, the proportion of cells in the G0/G1 phase was increased and those in the S-phase decreased.
  
  
  CONCLUSIONS
  QHF combined with DDP could significantly inhibit tumor growth, induce the apoptosis of tumor cells and effectively attenuate DDP toxicity.
authors.affiliation: Medical College of Three Gorges University, Yichang 443002, China.
authors.forename: Chen
authors.initials: C
authors.lastname: Tao
authors.forename: Li
authors.initials: L
authors.lastname: Dan
authors.forename: Fuya
authors.initials: F
authors.lastname: Ling
authors.forename: Gongzi
authors.initials: G
authors.lastname: Peng
keywords: Chinese medicine ingredients; QHF; apoptosis; cisplatin; hepatocellular carcinoma
references.citation: J Clin Epidemiol. 2002 Nov;55(11):1095-104
references.pmid: 12507673
references.citation: Clin Radiol. 2005 Sep;60(9):1018-25
references.pmid: 16124984
references.citation: J Hepatol. 2004 Dec;41(6):1008-16
references.pmid: 15582135
references.citation: Biochem Biophys Res Commun. 2008 Nov 7;376(1):10-4
references.pmid: 18725206
references.citation: Surg Oncol. 2008 Jul;17(1):23-31
references.pmid: 17869095
references.citation: Crit Rev Oncol Hematol. 2008 Aug;67(2):113-23
references.pmid: 18308583
references.citation: J Immunol Methods. 2000 Sep 21;243(1-2):167-90
references.pmid: 10986414
references.citation: J Am Coll Surg. 2008 Jul;207(1):20-9
references.pmid: 18589357
references.citation: J Hepatol. 2005 Sep;43(3):458-64
references.pmid: 16005538
references.citation: Asian J Surg. 2007 Oct;30(4):278-82
references.pmid: 17962132
references.citation: Methods Mol Biol. 2004;282:31-42
references.pmid: 15105555
references.citation: J Chin Med Assoc. 2005 Apr;68(4):155-9
references.pmid: 15850062
references.citation: Liver Transpl. 2002 Dec;8(12):1165-74
references.pmid: 12474157
references.citation: IDrugs. 2008 Mar;11(3):198-203
references.pmid: 18311657
references.citation: Chin Med J (Engl). 2008 Feb 20;121(4):363-8
references.pmid: 18304471
references.citation: J Hepatol. 2008 Dec;49(6):985-97
references.pmid: 18930332
references.citation: Cancer Lett. 2007 Aug 8;253(1):43-52
references.pmid: 17296261
references.citation: Cancer Lett. 2007 Apr 8;248(1):32-40
references.pmid: 16837130
references.citation: Tech Vasc Interv Radiol. 2007 Mar;10(1):2-11
references.pmid: 17980314
references.citation: J Hepatol. 2008;48 Suppl 1:S20-37
references.pmid: 18304676
references.citation: Zhongguo Zhong Yao Za Zhi. 2006 Jan;31(1):5-9
references.pmid: 16548156
references.citation: Eur J Pharmacol. 2008 Sep 4;591(1-3):13-20
references.pmid: 18599034
references.citation: Crit Rev Oncol Hematol. 2008 Jun;66(3):200-7
references.pmid: 18304832
references.citation: Eur J Ultrasound. 1999 May;9(2):145-53
references.pmid: 10413750
references.citation: J Hepatol. 2007 Jan;46(1):98-106
references.pmid: 17109987